These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 9376450)
41. Serotonergic and cognitive impairment in impulsive aggressive personality disordered offenders: are there implications for treatment? Dolan M; Deakin WJ; Roberts N; Anderson I Psychol Med; 2002 Jan; 32(1):105-17. PubMed ID: 11885567 [TBL] [Abstract][Full Text] [Related]
43. Positron emission tomography of regional brain metabolic responses to a serotonergic challenge in major depressive disorder with and without borderline personality disorder. Oquendo MA; Krunic A; Parsey RV; Milak M; Malone KM; Anderson A; van Heertum RL; John Mann J Neuropsychopharmacology; 2005 Jun; 30(6):1163-72. PubMed ID: 15770239 [TBL] [Abstract][Full Text] [Related]
44. Effect of fluoxetine on blood concentrations of serotonin, cortisol and dehydroepiandrosterone in canine aggression. Rosado B; García-Belenguer S; León M; Chacón G; Villegas A; Palacio J J Vet Pharmacol Ther; 2011 Oct; 34(5):430-6. PubMed ID: 21198677 [TBL] [Abstract][Full Text] [Related]
45. Plasma oxytocin in response to pharmaco-challenge to D-fenfluramine and placebo in healthy men. Lee R; Garcia F; van de Kar LD; Hauger RD; Coccaro EF Psychiatry Res; 2003 May; 118(2):129-36. PubMed ID: 12798977 [TBL] [Abstract][Full Text] [Related]
46. Neurohormonal responses to D-fenfluramine in healthy elderly subjects. A placebo-controlled study. Ramasubbu R; Flint A; Brown G; Awad G; Kennedy S Psychoneuroendocrinology; 2000 Feb; 25(2):139-50. PubMed ID: 10674278 [TBL] [Abstract][Full Text] [Related]
47. Use of fluoxetine to treat dominance aggression in dogs. Dodman NH; Donnelly R; Shuster L; Mertens P; Rand W; Miczek K J Am Vet Med Assoc; 1996 Nov; 209(9):1585-7. PubMed ID: 8899022 [TBL] [Abstract][Full Text] [Related]
48. Central serotonergic activity is related to the aggressive behaviors of Alzheimer's disease. Lanctôt KL; Herrmann N; Eryavec G; van Reekum R; Reed K; Naranjo CA Neuropsychopharmacology; 2002 Oct; 27(4):646-54. PubMed ID: 12377401 [TBL] [Abstract][Full Text] [Related]
49. LY393558, a 5-hydroxytryptamine reuptake inhibitor and 5-HT(1B/1D) receptor antagonist: effects on extracellular levels of 5-hydroxytryptamine in the guinea pig and rat. Mitchell SN; Greenslade RG; Cooper J Eur J Pharmacol; 2001 Nov; 432(1):19-27. PubMed ID: 11734183 [TBL] [Abstract][Full Text] [Related]
50. Do the endocrine and subjective effects of d-fenfluramine predict response to selective serotonin reuptake inhibitors? Park SB; Williamson DJ; Cowen PJ Int Clin Psychopharmacol; 1995 Nov; 10(4):215-20. PubMed ID: 8748042 [TBL] [Abstract][Full Text] [Related]
51. [Serotonergic function and aggressive-impulsive behavior]. Ayuso Gutiérrez JL Acta Psiquiatr Psicol Am Lat; 1994 Mar; 40(1):56-62. PubMed ID: 7519817 [TBL] [Abstract][Full Text] [Related]
52. Impulsive aggression in borderline personality disorder. Goodman M; New A Curr Psychiatry Rep; 2000 Feb; 2(1):56-61. PubMed ID: 11122933 [TBL] [Abstract][Full Text] [Related]
53. Acute tryptophan depletion attenuates the prolactin response to d-fenfluramine challenge in healthy human subjects. Coccaro EF; Kavoussi RJ; Cooper TB; Hauger R Psychopharmacology (Berl); 1998 Jul; 138(1):9-15. PubMed ID: 9694521 [TBL] [Abstract][Full Text] [Related]
54. 5-HT3 receptor antagonism by ondansetron does not attenuate prolactin response to d-fenfluramine challenge in healthy human subjects. Coccaro EF; Kavoussi RJ; Cooper TB; Hauger R Psychopharmacology (Berl); 1996 Sep; 127(2):108-12. PubMed ID: 8888375 [TBL] [Abstract][Full Text] [Related]
55. Increased sensitivity of the serotonergic system during the breeding season in free-living American tree sparrows. Sperry TS; Moore IT; Meddle SL; Benowitz-Fredericks ZM; Wingfield JC Behav Brain Res; 2005 Feb; 157(1):119-26. PubMed ID: 15617778 [TBL] [Abstract][Full Text] [Related]
56. Serotonergic function and self-injurious behavior in personality disorder patients. New AS; Trestman RL; Mitropoulou V; Benishay DS; Coccaro E; Silverman J; Siever LJ Psychiatry Res; 1997 Mar; 69(1):17-26. PubMed ID: 9080541 [TBL] [Abstract][Full Text] [Related]
57. Effects of acute treatment with 8-OH-DPAT and fluoxetine on aggressive behaviour in male song sparrows (Melospiza melodia morphna). Sperry TS; Thompson CK; Wingfield JC J Neuroendocrinol; 2003 Feb; 15(2):150-60. PubMed ID: 12535157 [TBL] [Abstract][Full Text] [Related]
58. Serotonin (5-HT) transporter ligands affect plasma 5-HT in rats. Rothman RB; Zolkowska D; Baumann MH Ann N Y Acad Sci; 2008 Oct; 1139():268-84. PubMed ID: 18991872 [TBL] [Abstract][Full Text] [Related]
59. Fluoxetine and norfluoxetine stereospecifically and selectively increase brain neurosteroid content at doses that are inactive on 5-HT reuptake. Pinna G; Costa E; Guidotti A Psychopharmacology (Berl); 2006 Jun; 186(3):362-72. PubMed ID: 16432684 [TBL] [Abstract][Full Text] [Related]
60. Impulsivity, gender, and response to fenfluramine challenge in borderline personality disorder. Soloff PH; Kelly TM; Strotmeyer SJ; Malone KM; Mann JJ Psychiatry Res; 2003 Jul; 119(1-2):11-24. PubMed ID: 12860356 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]